Fennec Pharmaceuticals Inc (FENC) — Cash Flow-to-Debt Ratio
Fennec Pharmaceuticals Inc (FENC) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of $50.00K could theoretically repay 0% of its total liabilities ($33.31 Million) in one year. See FENC financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fennec Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Fennec Pharmaceuticals Inc across 26 annual periods. For the full cash flow conversion analysis, see Fennec Pharmaceuticals Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Fennec Pharmaceuticals Inc (1999–2025)
Year-by-year debt coverage analysis for Fennec Pharmaceuticals Inc. Check cash flow quality index of Fennec Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.36x | $-12.47 Million | $35.02 Million | ▼ -167.1% |
| 2024 | 0.53x | $26.98 Million | $50.82 Million | ▲ +219.2% |
| 2023 | -0.45x | $-17.14 Million | $38.49 Million | ▲ +27.2% |
| 2022 | -0.61x | $-18.06 Million | $29.51 Million | ▲ +71.4% |
| 2021 | -2.14x | $-14.22 Million | $6.64 Million | ▲ +67.8% |
| 2020 | -6.64x | $-15.60 Million | $2.35 Million | ▼ -66.6% |
| 2019 | -3.99x | $-9.06 Million | $2.27 Million | ▲ +16.6% |
| 2018 | -4.78x | $-7.83 Million | $1.64 Million | ▼ -115.9% |
| 2017 | -2.21x | $-3.64 Million | $1.64 Million | ▲ +58.1% |
| 2016 | -5.28x | $-2.12 Million | $402.00K | ▼ -33.7% |
| 2015 | -3.95x | $-1.86 Million | $471.00K | ▼ -309.3% |
| 2014 | -0.97x | $-1.70 Million | $1.76 Million | ▼ -40.2% |
| 2013 | -0.69x | $-2.21 Million | $3.21 Million | ▼ -68.5% |
| 2012 | -0.41x | $-2.99 Million | $7.32 Million | ▲ +30.7% |
| 2011 | -0.59x | $-3.23 Million | $5.47 Million | ▼ -233.9% |
| 2010 | -0.18x | $-1.93 Million | $10.92 Million | ▲ +98.4% |
| 2009 | -10.98x | $-4.69 Million | $427.00K | ▼ -205.5% |
| 2008 | -3.59x | $-10.81 Million | $3.01 Million | ▲ +17.3% |
| 2007 | -4.35x | $-13.30 Million | $3.06 Million | ▼ -190.2% |
| 2006 | -1.50x | $-13.47 Million | $9.00 Million | ▼ -2.4% |
| 2005 | -1.46x | $-12.26 Million | $8.39 Million | ▼ -113.1% |
| 2003 | -0.69x | $-5.99 Million | $8.73 Million | ▼ -30.7% |
| 2002 | -0.52x | $-5.43 Million | $10.35 Million | ▲ +88.0% |
| 2001 | -4.39x | $-3.23 Million | $736.04K | ▼ -3.7% |
| 2000 | -4.23x | $-2.69 Million | $635.41K | ▼ -106.2% |
| 1999 | -2.05x | $-1.22 Million | $596.46K | — |